
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Rosacea may look like acne, but it is a vascular, inflammatory disease. Learn to identify, prevent, and treat this disfiguring condition.
Ted Rosen, MD, Professor of Dermatology at Baylor College of Medicine, offers bite-size pieces of useful clinical information on the “Top 10” skin disorders you see in your daily practice.
Segment 5: Rosacea
For more webinar videos,